NDA 019264 · Fresenius Kabi USA
Pentam
Pentamidine Isethionate · Injection
NovelPriority reviewOrphanLast checked: Nov 19, 2026Latest source record: Jan 8, 2014 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1984
Oct 16, 1984
Approved uses
1
Original approval plus efficacy supplements
Registered trials
48
13 Phase 3, 2 recruiting
FAERS reports
1,115
1,019 serious, 201 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Sep 13, 2022.
INDICATIONS AND USAGE Pentam 300 (pentamidine isethionate for injection) is indicated for the treatment of pneumonia due to Pneumocystis carinii .
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Oct 16, 1984 Original approval · Type 1 - New Molecular Entity · priority review
1 products under this application
- PENTAM · PENTAMIDINE ISETHIONATE 300MG/VIAL · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Pentamidine Isethionate" as an intervention, any sponsor and status, largest first.
- Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)Pivotal-lookingNot yet recruiting
Institute of Tropical Medicine, BelgiumAcademic, hospital or other
NCT07463040 · 900 participants (planned) · Start Jan 1, 2027 · Primary completion Mar 1, 2029
Drug: Sodium Stibogluconate (SSG); Miltefosine and 3 more · For: Cutaneous Leihmaniasis
Sites: Addis Ababa, Ethiopia; Arba Minch, Ethiopia; Boru, Ethiopia
- A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXPivotal-lookingCompleted
Glaxo WellcomeGSK (GSK)
NCT00002340 · 615 participants
Drug: Atovaquone; Pentamidine isethionate · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: Maitland, Florida; Tampa, Florida; New York, New York · 5 sites in all
- A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected PatientsPivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00000991 · 600 participants
Drug: Pentamidine isethionate; Sulfamethoxazole-Trimethoprim and 2 more · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: Los Angeles, California; Oakland, California; San Diego, California · 21 sites in all
- A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Pivotal-lookingNot yet recruiting
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT07917754 · 470 participants (planned) · Start Dec 13, 2026 · Primary completion Mar 13, 2037
Drug: MK-1045; Zilovertamab vedotin and 8 more · For: Lymphoma, Large B-Cell, Diffuse; Diffuse Large B-Cell Lymphoma
- Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)Pivotal-lookingNot yet recruiting
McGill University Health Centre/Research Institute of the McGill University Health CentreAcademic, hospital or other
NCT07357103 · 416 participants (planned) · Start Mar 2026 · Primary completion Mar 2029
Drug: Clindamycin + primaquine; Pentamidine and 1 more · For: Pneumocystis; Pneumocystis Infection; Pneumocystis Carinii Infection and 5 more
- A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or SulfonamidesPivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00001028 · 400 participants
Drug: Pentamidine isethionate; Dapsone · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: San Francisco, California; Denver, Colorado; Wilmington, Delaware · 14 sites in all
- Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSPivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00001013 · 364 participants
Drug: Trimetrexate glucuronate; Pentamidine isethionate and 2 more · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: Los Angeles, California; Washington D.C., District of Columbia; Miami, Florida · 23 sites in all
- A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)Pivotal-lookingCompleted
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT00000727 · 322 participants
Drug: Pentamidine isethionate; Pyrimethamine and 3 more · For: Pneumonia, Pneumocystis Carinii; HIV Infections
Sites: Los Angeles, California; San Diego, California; San Francisco, California · 9 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- febrile neutropenia133
- pyrexia126
- off label use87
- aplastic anaemia77
- neutropenia73
- diarrhoea72
- mucosal inflammation57
- pneumonia57
- sepsis54
- pancytopenia52
- dyspnoea48
- nausea48
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 11 |
| 2005 | 19 |
| 2006 | 45 |
| 2007 | 45 |
| 2008 | 38 |
| 2009 | 64 |
| 2010 | 107 |
| 2011 | 61 |
| 2012 | 51 |
| 2013 | 25 |
| 2014 | 12 |
| 2015 | 16 |
| 2016 | 35 |
| 2017 | 23 |
| 2018 | 24 |
| 2019 | 49 |
| 2020 | 69 |
| 2021 | 89 |
| 2022 | 95 |
| 2023 | 38 |
| 2024 | 90 |
| 2025 | 69 |
| 2026 | 40 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review.
Piccica M, Lagi F, Bartoloni A, et al. · J Travel Med 2021 · Research Support, Non-U.S. Gov't, Systematic Review
- Effect of antimicrobial and anti-inflammatory medications on the sense of taste.
Schiffman SS, Zervakis J, Westall HL, et al. · Physiol Behav 2000 · Clinical Trial, Controlled Clinical Trial
- Randomized single-blinded non-inferiority trial of 7 mg/kg pentamidine isethionate versus 4 mg/kg pentamidine isethionate for cutaneous leishmaniaisis in Suriname.
Hu RV, Straetemans M, Kent AD, et al. · PLoS Negl Trop Dis 2015 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
Hughes WT, Feldman S, Chaudhary SC, et al. · J Pediatr 1978 · Clinical Trial, Comparative Study
- Alveolar targeting of aerosol pentamidine. Toward a rational delivery system.
Simonds AK, Newman SP, Johnson MA, et al. · Am Rev Respir Dis 1990 · Clinical Trial, Controlled Clinical Trial
- Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine.
Young RC, DeVita VT · Natl Cancer Inst Monogr 1976 · Clinical Trial, Comparative Study
Sponsor: Fresenius Kabi USA
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.